Delivery Order SPE2DB22D1106-SPE2DB25FFGB9
- Not listed
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $7,542.83 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4564247323 - Ketorolac 0.5% Ophthalmic Solution 5ML. The contract has an ultimate completion date of April 12, 2024. This delivery order is issued under Amerisourcebergen's single-award indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Ketorolac 0.5% ophthalmic solution (5 ml). The delivery order, valued at $1,166.40, has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and effective through December 31, 2025. This IDC serves...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ketorolac 30 mg/mL vials with a ceiling value of $1,002.57. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $4,830 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac ophthalmic solution. As the prime contractor, Amerisourcebergen will supply 10mL bottles of the 0.5% strength ophthalmic solution to meet DLA requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 30 to August 31, 2023. The delivery order was issued under DLA's pharmaceuticals and...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/ml vials valued at $7,762.71 on August 11, 2025, with completion scheduled for August 12, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency Medical Supply Chain awarded a $7,301.66 delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials, with an ultimate completion date of August 13, 2025. This competitive award represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems through its...
- The Defense Logistics Agency awarded a $102 delivery order to Amerisourcebergen Drug Corporation for ketorolac ophthalmic solution. As the prime contractor, Amerisourcebergen will supply 5mL bottles of the 0.4% strength ophthalmic solution to meet needs under the agency's pharmaceutical programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three-day period in early September 2023. The firm fixed price contract type provides certainty of cost to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ketorolac 60 mg/2 ml vials with a ceiling value of $2,228.38. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. As a child contract, this...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), which provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. The $6,901.75 Delivery Order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the federal government, including the Department of Defense (DoD) and Veterans Affairs (VA). The...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ketorolac 30 mg/mL vials valued at $2,795.75. This is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location. The contract is issued as...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFGB9Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,348.64 for Ketorolac 0.5% ophthalmic solution in 5ML units on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies comprehensive pharmaceutical products and medical supplies to military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a global pharmaceutical support vehicle enabling the company to supply an extensive range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The Defense Logistics Agency's strategic approach includes planning for Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving federal healthcare customers including the Defense Health Agency and U.S. Coast Guard through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/29/25 |